This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan
- Accurate Dosimetry in 131I Radionuclide Therapy Using Patient-Specific, 3-Dimensional Methods for SPECT Reconstruction and Absorbed Dose Calculation
- Correlation of Tumor Radiation-Absorbed Dose with Response Is Easier to Find in Previously Untreated Patients
- Update on Hybrid Conjugate-View SPECT Tumor Dosimetry and Response in 131I-Tositumomab Therapy of Previously Untreated Lymphoma Patients
- An Activity Quantification Method Based on Registration of CT and Whole-Body Scintillation Camera Images, with Application to 131I
- Registration of Emission and Transmission Whole-Body Scintillation-Camera Images
- Accuracy of 131I Tumor Quantification in Radioimmunotherapy Using SPECT Imaging with an Ultra-High-Energy Collimator: Monte Carlo Study